• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

49.12 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,664
Open 49.12
Bid (Size) 49.11 (100)
Ask (Size) 49.13 (600)
Prev. Close 49.12
Today's Range 49.12 - 49.12
52wk Range 32.38 - 51.46
Shares Outstanding 5,385,189,617
Dividend Yield 3.40%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Moderna’s High-Stakes Transformation: Navigating the Post-Pandemic Pivot
January 14, 2026
Once the poster child for the biotechnology sector’s rapid response to the global pandemic, Moderna, Inc. (Nasdaq: MRNA) finds itself at a critical crossroads in early 2026. After a tumultuous period... 
Via Finterra
Topics Initial Public Offering Intellectual Property
News headline image
The Tariff Paradox: How Trump's 'Liberation Day' Protectionism Sparked a $2.3 Trillion M&A Feeding Frenzy
January 13, 2026
As of mid-January 2026, the American economic landscape is witnessing a phenomenon few analysts predicted a year ago. Despite the sweeping protectionist measures introduced under President Trump’s... 
Via MarketMinute
Topics Artificial Intelligence Economy Government

Performance

YTD
-1.0%
-1.0%
1 Month
+0.7%
+0.7%
3 Month
+12.2%
+12.2%
6 Month
+34.7%
+34.7%
1 Year
+49.8%
+49.8%

More News

Read More
News headline image
The mRNA Pivot: Moderna Navigates Regulatory Headwinds and Tariff Turmoil in a Volatile 2026 Biotech Landscape
January 12, 2026
Via MarketMinute
Topics Economy Intellectual Property World Trade
News headline image
BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism
January 09, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
Moderna’s Second Act: A 2026 Deep Dive into the Future of mRNA Therapeutics
January 09, 2026
Via PredictStreet
Topics Initial Public Offering Intellectual Property
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs ↗
January 08, 2026
Via Stocktwits
Topics Government
News headline image
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Moderna’s Second Act: Analyzing the 2026 Pipeline Pivot and Recent Stock Surge
January 07, 2026
Via PredictStreet
Topics Economy Initial Public Offering Intellectual Property
News headline image
US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And GSK ↗
January 06, 2026
Via Benzinga
News headline image
U.S. Scales Back The Number Of Vaccines It Recommends For Every Child ↗
January 05, 2026
Via Stocktwits
Topics Government
News headline image
Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗
January 05, 2026
Via MarketBeat
Topics Artificial Intelligence Death
News headline image
Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report ↗
December 31, 2025
Via Stocktwits
Topics Economy Government
News headline image
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
December 30, 2025
Via MarketMinute
Topics Product Recall
News headline image
Achieve Life Sciences’ Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook ↗
December 30, 2025
Via Stocktwits
News headline image
The Dynavax Turnaround: From Clinical Setbacks to a $2.2 Billion Exit
December 26, 2025
Via PredictStreet
News headline image
The Great Vaccine Consolidation: Sanofi’s $2.2 Billion Strategic Bet on Dynavax Technologies
December 25, 2025
Via PredictStreet
Topics Economy Intellectual Property
News headline image
The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
December 25, 2025
Via PredictStreet
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery
December 24, 2025
Via PredictStreet
Topics Initial Public Offering
News headline image
Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine
December 24, 2025
Via PredictStreet
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition
December 24, 2025
Via PredictStreet
Topics Economy
News headline image
Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring
December 24, 2025
Via MarketMinute
Topics Intellectual Property
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
December 23, 2025
Via Stocktwits
Topics Government
News headline image
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
December 22, 2025
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
December 22, 2025
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
GSK PLC-SPON ADR (NYSE:GSK) Shows Strong Technical Setup for Potential Breakout ↗
December 20, 2025
Via Chartmill

Frequently Asked Questions

Is GSK plc American Depositary Shares (Each representing two Ordinary Shares) publicly traded?
Yes, GSK plc American Depositary Shares (Each representing two Ordinary Shares) is publicly traded.
What exchange does GSK plc American Depositary Shares (Each representing two Ordinary Shares) trade on?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) trades on the New York Stock Exchange
What is the ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares) is GSK on the New York Stock Exchange
What is the current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 49.12
When was GSK plc American Depositary Shares (Each representing two Ordinary Shares) last traded?
The last trade of GSK plc American Depositary Shares (Each representing two Ordinary Shares) was at 01/15/26 07:00 PM ET
What is the market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 264.52B
How many shares of GSK plc American Depositary Shares (Each representing two Ordinary Shares) are outstanding?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) has 265B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap